D-0213-2018 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0213-2018 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 9, 2017 and is designated Class II. Reason for recall: Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off. The recall status is terminated (terminated Dec 4, 2018). Affected quantity: 1,051 vials.

Recall details

Product Type
Drugs
Report Date
Jan 17, 2018
Initiation Date
Jan 9, 2017
Termination Date
Dec 4, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,051 vials

Product description

Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11

Reason for recall

Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.

Distribution pattern

Distributed nationwide in the USA, Uzbekistan, and Myanmar

Code information

Lot #: H7044, Exp 05/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0213-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0213-2018. Report a data issue: hello@regdatalab.com.